Purdue and Transcept in Insomnia Drug Deal
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 8 (Table of Contents)
Published: 14 Aug-2009
DOI: 10.3833/pdr.v2009.i8.1171 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Purdue Pharmaceuticals and Transcept entered into an exclusive license and collaboration agreement to commercialise the insomnia drug, Intermezzo® (zolpidem tartrate sublingual tablet), in the United States in a deal valued at US$145 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS